| Date Filed | Type | Description |
| 08/15/2023 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Sold 28,975 shares
@ $14.9306, valued at
$432.6k
|
|
| 08/14/2023 |
4
| MCHUGH THOMAS S (CFO) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Bought 2,000 shares
@ $14.45, valued at
$28.9k
|
|
| 08/11/2023 |
4
| Glass Geoffrey Michael (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Bought 14,000 shares
@ $13.4, valued at
$187.6k
|
|
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
4
| Divis Gregory J (CEO) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Bought 10,000 shares
@ $13.1997, valued at
$132k
|
|
| 08/10/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 12.3% stake in AVADEL PHARMACEUTICALS PLC |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
4
| Ende Eric J (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 33,000 options to buy
@ $14.1, valued at
$465.3k
|
|
| 08/03/2023 |
4
| Glass Geoffrey Michael (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 33,000 options to buy
@ $14.1, valued at
$465.3k
|
|
| 08/03/2023 |
4
| McCamish Mark Anthony (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 33,000 options to buy
@ $14.1, valued at
$465.3k
|
|
| 08/03/2023 |
4
| Palczuk Linda (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 33,000 options to buy
@ $14.1, valued at
$465.3k
|
|
| 08/03/2023 |
4
| Thornton Peter J. (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Granted 33,000 options to buy
@ $14.1, valued at
$465.3k
|
|
| 08/03/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ... |
| 08/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/31/2023 |
8-K
| Other Events Interactive Data |
| 05/19/2023 |
4
| Ende Eric J (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Bought 13,000 shares
@ $13.9308, valued at
$181.1k
|
|
| 05/10/2023 |
4
| Palczuk Linda (Director) has filed a Form 4 on AVADEL PHARMACEUTICALS PLC|
Txns:
| Bought 2,500 shares
@ $14.76, valued at
$36.9k
|
|
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 04/03/2023 |
8-K
| Other Events Interactive Data |
| 03/30/2023 |
8-K
| Quarterly results |
| 03/30/2023 |
8-K/A
| Quarterly results |
| 03/29/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/22/2023 |
8-K
| Quarterly results |
| 03/09/2023 |
SC 13G
| KOTLER KEVIN reports a 5.1% stake in Avadel Pharmaceuticals plc |
| 03/02/2023 |
8-K
| Other Events Interactive Data |
| 02/24/2023 |
8-K
| Other Events Interactive Data |
| 02/14/2023 |
SC 13G/A
| GENDELL JEFFREY L reports a 8.4% stake in Avadel Pharmaceuticals plc |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|